U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07224438) titled 'Kisspeptin Administration Subcutaneously to Patients With Hypothalamic Amenorrhea' on Nov. 03.
Brief Summary: The goal of this study is to see whether kisspeptin, a naturally occurring hormone, can stimulate the release of other reproductive hormones in women with hypothalamic amenorrhea (HA). The investigators are also examining whether kisspeptin can help women release eggs from their ovaries. Kisspeptin will be administered subcutaneously (SC) for two weeks in a pulsatile fashion. Ultrasound monitoring of ovarian follicular growth and frequent blood sampling (every 10 minutes for up to two hours) will be performed to assess the ph...